Please assess the completion status of the following clinical trial:

Trial Title: Atropine-effect During Propofol/Remifentanil Induction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients requiring general anaesthesia;~* Patient's age ≥ 18 years and older;~* Patient and surgical procedure appropriate for treatment with either sufentanil or remifentanil.~Exclusion Criteria:~* Patient's refusal;~* Pregnancy;~* Patient's age \< 18 years;~* Patients in which atropine is contra-indicated, such as severe aortic valve stenosis, hypertrophic cardiomyopathy or coronary artery disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- General anesthesia + placebo (Type: PLACEBO_COMPARATOR): Propofol/remifentanil anesthesia + saline
- General anesthesia + atropine (Type: ACTIVE_COMPARATOR): Propofol/remifentanil anesthesia + atropine

Based on this trial design, predict the completion outcome and termination type (if applicable).